AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
May 112016
 

Lupin to co-market Novartis’ asthma drug in India

Business Standard

BS B2B Bureau  |  Mumbai April 12, 2016 Last Updated at 10:27 IST

Novartis Healthcare will continue to market Sequadra (indacaterol/glycopyrronium inhaler), while Lupin will promote the inhaler under the brand name Loftair in India

read original article at

http://www.business-standard.com/content/b2b-pharma/lupin-to-co-market-novartis-asthma-drug-in-india-116041200249_1.html

 

/////inhaler, Novartis Healthcare,  Sequadra, indacaterol, glycopyrronium inhaler,  Lupin,  inhaler,  brand name,  Loftair, India

Share

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: